Insight Molecular Diagnostics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -98.3% | -98.3% | -40.2% |
| FY2022 | -212.6% | -212.6% | -72.8% |
| FY2023 | -135.7% | -135.7% | -37.1% |
| FY2024 | 494.2% | 494.2% | -172.9% |
| FY2025 | 159.6% | 159.6% | -195.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -98.3% | -98.3% | -40.2% |
| FY2022 | -212.6% | -212.6% | -72.8% |
| FY2023 | -135.7% | -135.7% | -37.1% |
| FY2024 | 494.2% | 494.2% | -172.9% |
| FY2025 | 159.6% | 159.6% | -195.0% |